On Tuesday, the Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) deliberated upon Hyderabad-based Bharat Biotech’s application seeking permission to conduct the clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs among children.
